WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Apparatus and method for continuous non-invasive cardiovascular monitoring    

Get related patents on CD
United States Patent4669485   
Link to this pagehttp://www.wikipatents.com/4669485.html
Inventor(s)Russell; Ted W. (Northport, NY)
AbstractApparatus and related methods for continuous long-term non-invasive measurement of the pressure of a pulsatile fluid flowing through a flexible tube, particularly human arterial blood flow, is disclosed. Specifically, the apparatus provides a continuous calibrated pressure measurement by first undertaking a "calibration" phase comprised of determining the pressure at various pre-defined conditions of flow and, in reponse thereto, ascertaining the values of a plurality of coefficients each of which is associated with a corresponding term in a pre-defined function that characterizes fluid pressure in relation to pulsatile displacement of the wall of the tube; and second, undertaking a "continuous monitoring" phase comprised of determining each subsequently occurring pressure value as the pre-defined function of each corresponding pulsatile wall displacement value, and re-initiating the calibration phase at the expiration of pre-defined time intervals which adaptively change based upon current and prior results. Methods, which are particularly useful in conjunction with the disclosed apparatus, for ascertaining systolic and diastolic arterial blood pressure values are also disclosed.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History Custom Search
Inventor     Russell; Ted W. (Northport, NY)
Owner/Assignee     Cortronic Corporation (Ronkonkoma, NY)
Patent assignment
All assignments
Company News
Publication Date     June 2, 1987
Application Number     06/581,134
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     February 17, 1984
US Classification     600/492 600/493
Int'l Classification     A61B 005/02
Examiner     Howell; Kyle L.
Assistant Examiner     Sykes; Angela D.
Attorney/Law Firm     Stanger, Michaelson and Einschlag
Address
Parent Case    
Priority Data    
USPTO Field of Search     128/672 128/677 128/678 128/679 128/680 128/681 128/682 128/683 128/684 128/685 128/686
Patent Tags     continuous non-invasive cardiovascular monitoring
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
3157177



[0 after 0 votes]
3348534



[0 after 0 votes]
3581734



[0 after 0 votes]
3903872



[0 after 0 votes]
4479494
McEwen
606/202
Oct,1984

[0 after 0 votes]
4437469
Djordjevich
600/485
Mar,1984

[0 after 0 votes]
4418700
Warner
600/507
Dec,1983

[0 after 0 votes]
4408614
Weaver
600/493
Oct,1983

[0 after 0 votes]
4407297
Croslin
600/494
Oct,1983

[0 after 0 votes]
4378807
Peterson
600/490
Apr,1983

[0 after 0 votes]
4349034
Ramsey, III
600/494
Sep,1982

[0 after 0 votes]
4343314
Sramek
600/493
Aug,1982

[0 after 0 votes]
4313445
Georgi
600/493
Feb,1982

[0 after 0 votes]
4271843
Flynn
600/494
Jun,1981

[0 after 0 votes]
4271844
Croslin
600/494
Jun,1981

[0 after 0 votes]
4262675
Kubo
600/493
Apr,1981

[0 after 0 votes]
4245648
Trimmer
600/493
Jan,1981

[0 after 0 votes]
4216779
Squires
600/495
Aug,1980

[0 after 0 votes]
4105021
Williams
600/496
Aug,1978

[0 after 0 votes]
4074711
Link
600/494
Feb,1978

[0 after 0 votes]
4009709
Link
600/494
Mar,1977

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B

[0 market size comments]
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 market share comments]
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 reasonable royalty comments]
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

[0 Guesstimation of Royalty Value Comments]
License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 license availability comments]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 owner/assignee comments]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

[0 competitive advantage comments]
Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

[0 commercial alternatives comments]
 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


I claim:

1. A method tor use in determining arterial blood pressure in a subject comprising the steps of:

undertaking a calibration phase comprised of the steps of determining blood pressure and arterial wall displacement values of said subject occurring in response to corresponding initial conditions of blood flow, and ascertaining, in response to said determined values, the values of a plurality of coefficients, each of which is associated with a corresponding term in a pre-defined relationship that characterizes arterial blood pressure as a function of arterial wall displacement,

undertaking a continuous monitoring phase comprised of the steps of measuring subsequently occurring actual arterial wall displacement values, generating a corresponding blood pressure value in response to said relationship and to at least one of each of said actual arterial displacement values, and repeating said calibration phase at the occurrence of any one of a plurality of pre-defined events or at pre-defined times.

2. The method of claim 1 wherein said continuous monitoring phase undertaking step is further comprised of the step or varying said times in response to differences between the most recent value and a corresponding prior value of at least one of said coefficients.

3. The method of claim 2 wherein said generating step is further comprised of the step of producing various measurement parameters based upon said generated blood pressure values.

4. The method of claim 3 wherein said repeating step is comprised of the steps of:

checking various ones of said measurement parameters against corresponding limit values, and

repeating said calibration phase whenever at least one of said measurement parameters exceeds its corresponding limit value.

5. The method of claim 1 wherein said determining step is comprised of the steps of:

affixing at least one arterial occluding device to at least one limb of a subject,

controllably operating said occluding device to non-invasively occlude an artery within said limb and thereby establish an initial condition of arterial blood flow,

sensing perturbations, in the arterial blood flow through said occluding device, as said device reduces its occlusion at a controlled rate so as to establish other initial conditions of arterial blood flow, and

determining, in response to the value of said perturbations, values of arterial blood pressure and arterial wall displacement occurring at each of said initial conditions of arterial blood flow.

6. The method of claim 5 in which said operating step further includes the step of measuring said perturbations through said occluding device and controllably increasing the occlusion produced by said device to a value in excess of that required to eliminate said perturbations, whereby an initial condition of supra-systolic occlusion is achieved.

7. The method of claim 6 in which said measuring step includes the step of inflating a pneumatic cuff attached around a selected limb of the subject and sensing pulsatile perturbations occurring in the air contained in the cuff and attributable to pulsatile arterial blood flow.

8. The method of claim 7 in which said inflating step further includes the steps of:

attaching a relatively high pressure occlusive pneumatic cuff and a low pressure waveform sensing cuff around at least one limb of the subject,

controllably inflating the occlusive cuff first to a supra-systolic occlusive pressure and then deflating the occlusive cuff to a sub-diastolic occlusive pressure in order to produce said initial conditions of arterial blood flow,

inflating said low pressure waveform sensing cuff simultaneously with said occlusive cuff and thereafter maintaining air pressure at a substantially constant low pressure during deflation of said occlusive cuff, and

measuring the relative displacement of the arterial wall attributable to the arterial blood flow occurring for each of said initial conditions as a function of the simultaneously occurring pulsatile variation in the pressure of said waveform sensing cuff.

9. The method of claim 8 wherein the attaching step further includes the steps of securing the occlusive cuff around a selected limb of the subject and securing the waveform sensing cuff on the same limb but at a location distally situated from said occulsive cuff.

10. The method of claim 8 wherein the attaching step further includes the step of securing the occlusive and waveform sensing cuffs to different limbs of the subject.

11. The method of claim 10 wherein the securing step includes the step of positioning the occlusive and waveform sensing cuffs on opposite limbs of the subject.

12. The method of claim 1 wherein the ascertaining step further includes the step of substituting each of a pre-selected plurality of arterial wall displacement values into said pre-defined relationship in order to fabricate a table of arterial blood pressure values corresponding to said pre-selected plurality of displacement values.

13. The method of claim 12 wherein the generating step includes the step of using at least one of said actual arterial displacement values to access the table in order to determine a generated blood pressure value corresponding thereto.

14. The method of claim 13 wherein the generating step is further comprised of fabricating a sequence of present and previously generated blood pressure values for display on an historical basis.

15. The method of claim 14 wherein the generating step is further comprised of fabricating respective sequences of present and prior values for each of a plurality of measurement parameters, wherein said parameters are determined in response to said generated blood pressure values.

16. The method of claim 15 wherein the generating step is further comprised of providing a suitable notification whenever any value of any of said sequences exceeds a pre-defined limit value.

17. The method of claim 16 wherein the fabricating step includes the step of producing systolic and diastolic arterial blood pressure values.

18. The method of claim 1 wherein said determining step further includes the step of producing a systolic blood pressure value, and generating at least first and second diastolic blood pressure measures and selecting either one of said measures as a final diastolic pressure value in response to hemodynamic variability detected during said calibration phase.

19. The method of claim 18 wherein said systolic value producing step includes the steps of:

controllably deflating an occlusive cuff secured around a limb of the subject,

detecting a pre-determined number of pressure waveform peaks and simultaneously occurring corresponding occlusive cuff pressures occurring during occlusive cuff deflation,

determining a measure of the variability of these detected peaks,

defining co-ordinates of a first point in terms of an average of the detected peaks and an average of the corresponding occlusive cuff pressures,

successively maintaining the pressure of said occlusive cuff at a substantially constant value for a corresponding pre-selected time interval and detecting additional pressure waveform peaks and determining a second measure of the variability associated therewith during said corresponding time interval,

defining co-ordinates of a second point in terms of an average of said additional peaks and said constant pressure value,

modifying the values of the co-ordinates of said first and/or second points, in response to said first and/or second variability measures,

ascertaining an intermediate value of systolic pressure in terms of the co-ordinates of a point of intersection between a line defined by said first and second points and a line representing a pre-determined constant pressure value, and

modifying said intermediate systolic pressure value in response to said first and/or second variability measures so as to obtain a final systolic pressure value.

20. The invention in claim 19 in which said deflating step further includes the step of deflating the occlusive cuff at a pre-defined controlled linear rate.

21. The invention in claim 19 in which the peak detecting step includes the step of sampling pneumatic pressure of said occlusive cuff during each of a pre-defined number of sequentially occurring sampling windows, each of said windows being a pre-determined duration, to detect either a pressure waveform peak or an absent pulse occurring during any of said windows.

22. The invention in claim 21 in which the sampling step further includes the step of varying the duration of said sampling windows in response to either the actual heart-rate of the subject and/or previously occurring absent pulse windows.

23. The invention in claim 19 in which said maintaining step includes the step of selecting the duration of said pre-selected time interval based upon the number of pressure peaks and absent pulse windows and the order in which said peaks and absent pulse windows occur during this interval.

24. The invention in claim 23 in which said maintaining step further includes the step of determining the value of said variability measure in terms of the number of absent pulse windows detected during a pre-selected sequence of sampling windows.

25. The invention in claim 19 in which said intermediate systolic value ascertaining step includes the step of determining the x co-ordinate value of said point of intersection and setting said intermediate systolic value equal to the value of the x co-ordinate.

26. The invention in claim 18 in which said first diastolic measure generating step includes the steps of:

determining a group, of a pre-selected number of sequentially occurring individual pressure waveform values, from all the pressure waveforms occurring during deflation of an occlusive cuff, wherein said group possesses maximum average amplitude,

selecting, in accordance with pre-selected criteria, at least one individual pressure waveform from the group and setting mean pressure of the subject equal to the occlusive cuff pressure corresponding to the selected individual pressure waveform,

determining the systolic pressure of the subject, and

ascertaining the first measure of diastolic pressure in accordance with the formula: ##EQU2## for at least a chosen one of all of said pressure waveforms in which D is the first measure of diastolic pressure, A is the uncalibrated peak amplitude of said chosen pressure waveform, Y is the mean value (area/duration) of said chosen pressure waveform, and S and M are the systolic and mean pressure values respectively, associated with said subject.

27. The invention in claim 26 in which said selecting step is comprised of the steps of determining a second group of a preselected number of sequentially occurring pressure waveforms from all of said waveforms occurring subsequent to said selected individual pressure waveform.

28. The invention in claim 27 in which the selecting step includes the step of ascertaining the mean pressure as being subsequently equal to the occlusive cuff pressure occurring at the time of the peak of said selected individual pressure waveform.

29. The invention in claim 28 in which the first measure ascertaining step further includes the step of determining, in accordance with said formula, a diastolic pressure estimate for each pressure waveform in said second group and averaging all the estimates to produce said first measure of diastolic pressure.

30. The invention in claim 26 in which said individual pressure waveform selecting step is comprised of the steps of:

determining whether said selected individual waveform was caused by an artifact by comparing the peak amplitude of said selected individual waveform against a pre-determined limit, and

rejecting the selected individual waveform in the event the limit is exceeded and selecting another waveform until such limit is no longer exceeded.

31. The invention in claim 18 in which said second diastolic measure generating step includes the steps of:

a. establishing, in response to a sequence of occlusive pressure waveform peaks and corresponding occlusive cuff pressures occurring during deflation of the occlusive cuff, a sequence of mid-point co-ordinates, wherein one co-ordinate of each midpoint is an average of the peak amplitudes of two successive pressure waveforms and the other co-ordinate of each mid-point is an average of the occlusive cuff pressures corresponding to each of said two peaks,

b. grouping every mid-point into an alternate one of at least two series,

c. determining the value of slope of each of a plurality of line segments, wherein each segment joins a pair of adjacent midpoints in one of said sequences,

d. testing each of said slope values against pre-defined limits to determine whether any of said mid-points is attributable to a negator or a reversal,

e. removing any pressure waveform peak and its corresponding occlusive cuff pressure value attributable to a negator or a reversal from the sequence and repeating steps (a), (b), (c) and (d) until substantially all pressure waveform peaks attributable to either negators or reversals have been removed,

f. comparing the slope of each segment in each series against a pre-defined threshold and, in response thereto, choosing an appropriate one of the segments comprising each series,

g. choosing an appropriate pressure waveform peak amplitude value that precedes the leading midpoint associated with the chosen segment in each series, and

h. selecting one of the resulting chosen pressure waveform peak amplitude values as the second diastolic measure.

32. The invention in claim 31 wherein said selecting step includes the step of picking that one of the chosen waveform peak amplitude values which has the minimum peak amplitude as the second diastolic measure.

33. The invention in claim 18 wherein said selecting step includes the step of picking said first, said second, or an average of said first and second diastolic pressure measures for said final diastolic pressure value in response to a numerical difference between the values of said first and second measures and/or the number of negators and reversals determined during said second diastolic measuring step.

34. Apparatus for determining arterial blood pressure in a subject comprising:

means for undertaking a calibration phase comprising means for determining the blood pressure values occurring in response to corresponding initial conditions of blood flow, and means for ascertaining, in response to said determined blood pressure values, the values of a plurality of coefficients, each of which is associated with a corresponding term in a pre-defined relationship that characterizes arterial blood pressure as a function of arterial wall displacement,

means for undertaking a monitoring phase comprising means for measuring subsequently occurring acutal arterial wall displacement values, means for generating a corresponding blood pressure value in response to said relationship and to at least one of each of said actual arterial displacement values, and means for repeating said calibration phase at the occurrence of any one of a plurality of pre-defined events or at pre-defined times.

35. The apparatus of claim 34 wherein said monitoring phase undertaking means is further comprised of means for varying said times in response to differences between the most recent value and a corresponding prior value of at least one of said coefficients.

36. The apparatus of claim 35 wherein said generating means is further comprised of means for producing various measurement parameters based upon said generated blood pressure values.

37. The apparatus of claim 36 wherein said repeating means is comprised of:

means for checking various ones of said measurement parameters against corresponding limit values, and

means for repeating said calibration phase whenever at least one of said measurement parameters exceeds its corresponding limit value.

38. The apparatus of claim 37 wherein said determining means is comprised of:

means for occluding an artery situated in one limb of a subject,

means for controllably operating said occluding means to non-invasively occlude said artery within said limb and thereby establish an initial condition of arterial blood flow,

means for sensing perturbations, in the arterial blood flow through said occluding means, as said occluding means reduces its occlusion at a controlled rate so as to establish other initial conditions of arterial blood flow, and

means for determining, in response to the value of said perturbations, values of arterial blood pressure and arterial wall displacement occurring at each of said initial conditions of arterial blood flow.

39. The apparatus of claim 38 in which said operating means is comprised of: means for measuring said perturbations through said occluding means and controllably increasing the occlusion produced by said occluding means to a value in excess of that required to eliminate said perturbations, whereby an initial condition of supra-systolic occlusion is achieved.

40. The apparatus of claim 39 in which said measuring means includes means for inflating a pneumatic cuff attached around a selected limb of the subject and sensing pulsatile perturbations occurring in the air contained in the cuff and attributable to pulsatile arterial blood flow.

41. The apparatus of claim 40 in which said inflating means is comprised of:

a relatively high pressure occlusive pneumatic cuff and a low pressure waveform sensing cuff, each of which is attached around at least one limb of the subject,

means for controllably inflating the occlusive cuff first to a supra-systolic occlusive pressure and then deflating the occlusive cuff to a sub-diastolic occlusive pressure in order to produce said initial conditions of arterial blood flow,

means for inflating said low pressure waveform sensing cuff simultaneously with said occlusive cuff and thereafter maintaining air pressure at a substantially constant low pressure during deflation of said occlusive cuff, and

means for measuring the relative displacement of the arterial wall attributable to the arterial blood flow occurring for each of said initial conditions as a function of the simultaneously occurring pulsatile variation in the pressure of said waveform sensing cuff.

42. The apparatus of claim 41 wherein the occlusive cuff is secured around a selected limb of the subject and the waveform sensing cuff is secured around the same limb but at a location distally situated from said occlusive cuff.

43. The apparatus of claim 41 wherein the occlusive and waveform sensing cuffs are secured around different limbs of the subject.

44. The apparatus of claim 43 wherein the occlusive and waveform sensing cuffs are secured around opposite limbs of the subject.

45. The apparatus of claim 34 wherein the ascertaining means is comprised of means for substituting each of a pre-selected plurality of arterial wall displacement values into said pre-defined relationship in order to fabricate a table of arterial blood pressure values corresponding to said pre-selected plurality of displacement values.

46. The apparatus of claim 45 wherein the generating means comprises means for accessing the table, using at least one of said actual arterial displacement values, in order to determine a generated blood pressure value corresponding to said arterial displacement value.

47. The apparatus of claim 46 wherein the generating means is further comprised of means for fabricating a sequence of present and previously generated blood pressure values for display on an historical basis.

48. The apparatus of claim 47 wherein the generating means is further comprised of means for fabricating respective sequences of present and prior values for each of a plurality of measurement parameters, wherein said parameters are determined in response to said generated blood pressure values.

49. The apparatus of claim 48 wherein the generating means is further comprised of means for providing a suitable notification whenever any value of any of said sequences exceeds a pre-defined limit value.

50. The apparatus of claim 48 wherein the fabricating means is comprised of means for producing systolic and diastolic arterial blood pressure values.

51. A method for use in determining arterial blood pressure in a subject, comprising the steps of:

undertaking a calibration phase comprised of the steps of determining blood pressure values and values of a physiologic parameter of said subject related to blood pressure both values occurring in response to corresponding initial conditions of blood flow, and ascertaining, in response to said determined values, the values of a plurality of coefficients, each of which is associated with a corresponding term in a pre-defined relationship that characterizes arterial blood pressure as a function of said physiologic parameter; and

undertaking a continuous monitoring phase comprised of the steps of measuring subsequently occurring actual values of said physiologic parameter, generating a corresponding blood pressure value in response to said relationship and to at least one of each of said actual physiologic parameter values, and repeating said calibration phase at the occurrence of any one of a plurality of pre-defined events or at pre-defined times.

52. The method of claim 51 wherein the determining and measuring steps include the step of detecting the physiologic parameter through non-invatsive means or through perivascular invasive means, and wherein the physiologic parameter is proportional to arterial wall displacement, arterial blood flow, arterial blood volume or arterial blood velocity.

53. The method of claim 52 wherein the detecting step further includes the step of sensing said physiologic parameter through non-invasive strain gage plethysmography or electrical impedance plethysmography.

54. The method of claim 52 wherein said continuous monitoring phase further includes the step of varying said times in response to differences between the most recent value and a corresponding prior value of at least one of said coefficients.

55. The method of claim 54 wherein said generating step includes the step of producing various measurement parameters based upon said generated blood pressure values, and said repeating step includes the steps of: checking various ones of said measurement parameters against correponding limit values, and repeating said calibration phase whenever at least one of said measurement parameters exceeds its corresponding limit value.

56. The method of claim 52 wherein the ascertaining step further includes the step of substituting each of a pre-selected plurality of said physiologic parameter values into said pre-defined function in order to fabricate a table or arterial blood pressure values corresponding to said pre-selected plurality of physiologic parameter values, and said generating step further includes the step of using at least one of said actual physiologic parameter values to access the table in order to determine a generated blood pressure value corresponding thereto.

57. The method of claim 56 wherein the generating step further includes the step of fabricating a sequence of present and previously generated blood pressure values and, in response thereto, producing systolic and diastolic arterial blood pressure values.
 Description Submit all comments and votes
 


BACKGROUND OF THE INVENTION

1. Field of the Invention

The invention relates to an apparatus and various methods used therein for continuous non-invasive measurement of the pressure of a pulsatile fluid flowing through a flexible tube over relatively long time periods, with particular applicability to the measurement of human arterial blood pressure and other related cardiovascular parameters.

2. Description of the Prior Art

Often a need arises to monitor pulsatile fluid pressure in a vessel where a number of practical considerations preclude direct invasive measurement, i.e. using an appropriate pressure sensor directly implanted through the vessel and maintained in a suitable position within the fluidic flow. Considerations of this nature include avoiding: contamination of the fluid or its immediate environment by any foreign matter carried by the sensor, coagulation of the fluid, corrosive deterioration caused to the sensor by direct contact with the fluid, fluid loss from the vessel, or physical damage to the flexible vessel that contains the fluid.

These considerations have particular applicability to the measurement of arterial blood pressure of human (or other animal) patients or subjects. In practice, invasive pressure monitoring generally entails a surgical cut-down and arterial penetration using a hypodermic needle (cannula) through which pulsatile fluidic forces attributable to arterial blood flow are routed to a suitable pressure transducer. However, various medical health care risks associated with invading the human body, such as clotting, infection, emboli obstructions to flow, and/or major blood loss generally limit the use of invasive blood pressure monitoring systems to the most critical of acute care hospital patient monitoring situations. To minimize these risks, invasive monitoring is almost always used in conjunction with intravenous application of fluids to the patient. Disadvantageously, the various fluidic, mechanical and electrical components generally used in invasive systems are not only complex and fragile, but also require specialized calibration before use, as well as frequent surveillance by specially qualified staff. In spite of this surveillance, invasive systems often do not remain calibrated during prolonged periods of use and, as a result, often produce inaccurate and potentially misleading patient blood pressure measurements.

Consequently, over t